MENLO PARK, Calif.--(BUSINESS WIRE)--SPINAL MODULATION, Inc., a privately held medical device company focused on developing devices to treat chronic pain, today announced that the results of its ...

New delivery system, designed for Abbott's Proclaim™ DRG neurostimulation system, promotes efficient placement of neurostimulation leads on the dorsal root ganglion (DRG) Abbott's system is the only ...

For a few years now, specialists have been doing a procedure called Dorsal Root Ganglion Stimulation as a form of therapy for chronic pain. The treatment is a procedure where the dorsal root ganglion, ...

Chennai (Tamil Nadu) [India], November 20 (ANI): On pain management, a team of spine surgeons and pain specialists at a private hospital (Apollo Cancer Centre - ACC), Chennai, performed India's first ...

Please provide your email address to receive an email when new articles are posted on . Dorsal root ganglion neurostimulation therapy effectively decreased pain, increased function and created a ...

Chronic pain is among the millions of patients globally whose management becomes a real challenge after surgical damage to nerves. In this case, for instance, the technique of DRG stimulation aimed at ...

Researchers at the University of California San Diego are coming to the rescue of people with terrible pain in one part of their body. They're using a stimulator that goes directly on the dorsal root ...

Stimulating a specific set of nerves that are nestled along the spine may deliver relief to those who suffer from chronic back pain and cut the need for opioid painkillers, new research suggests. The ...

Abbott Laboratories (NYSE:ABT)‘s dorsal root ganglion (DRG) stimulation therapy has advantages over traditional spinal cord stimulation (SCS) in the treatment of patients suffering from complex ...

Availability of the dorsal root ganglion (DRG) therapy represents an important milestone in the treatment of chronic intractable pain conditions due to complex regional pain syndrome I and II ST. PAUL ...

Abbott announced the launch of its neuromodulation business’ next-generation delivery system, which will be used to streamline the implantation process for electrodes used as part of its Proclaim DRG ...